Clinical characteristics and sociodemográficas of patients acometidos for cardiac insufficience

2010 ◽  
Vol 4 (4) ◽  
pp. 1711
Author(s):  
Francisca Elisângela Teixeira Lima ◽  
Danielle Diógenes Nunes ◽  
Débora Lima Freitas ◽  
Ires Lopes Custódio ◽  
Francisca Lígia Medeiros Martins Santos ◽  
...  

ABSTRACTObjective: to evaluate the epidemiological aspects of patients with Heart Failure (HF) and identify the risk factors in patients with HF. Method: this is about a descriptive study, quantitative, performed in a hospital from Fortaleza-CE. The population was composed of patients hospitalized with HF, the sample comprising 100 patients who met the criteria for inclusion. Data were collected in records and interview. Approved by the Ethics Committee n.º 514/2008. Results: prominent mention as sociodemographic characteristics are: male (63%), age> 60 years (43%), presence of hereditary factors (48%), married (67%), retired (42%) and family income < 1 minimum wage (70%). Modifiable risk factors identified: hypertension (61%), diabetes (22%), overweight (40%), hyperlipidemia (18%), sedentary (82%) smokers (11%) and consumers of alcohol (15%). Conclusion: as we conclude, knowing the profile of the population that carry the HF is favorable to develop strategies for health education to prevent cardiovascular complications in people with higher number of risk factors. Descriptors: health profile; cardiovascular diseases; heart failure; nursing; health education; health promotion. RESUMOObjetivo: levantar as características sociodemográficas dos pacientes portadores de insuficiência cardíaca (IC) e identificar os fatores de risco modificáveis nos pacientes portadores de IC. Método: estudo descritivo, quantitativo, desenvolvido em hospital terciário de Fortaleza-CE. A população foi constituída por pacientes com IC hospitalizados, com amostra de 100 pacientes. Os dados foram coletados nos prontuários e em entrevista. Aprovado pelo comitê de ética sob parecer n.º 514/2008. Resultados: predominaram como características sociodemográficas: sexo masculino (63%); idade > 60 anos (43%); presença de fatores hereditários (48%); casados (67%); aposentados (42%) e com renda familiar < 1 salário mínimo (70%). Fatores de risco modificáveis detectados: hipertensão (61%); diabetes (22%); sobrepeso (40%); dislipidemia (18%); sedentários (82%); tabagistas (11%) e etilista (15%). Conclusão: conclui-se que conhecer o perfil da população portadora de IC é favorável para desenvolver estratégias de educação em saúde a fim de prevenir complicações cardiovasculares nas populações com fatores de risco. Descritores: perfil de saúde; doenças cardiovasculares; insuficiência cardíaca; enfermagem; educação em saúde; promoção da saúde.RESUMEN Objetivo: evaluar los aspectos epidemiológicos de los pacientes con insuficiencia cardiaca (IC) y identificar los factores de riesgo en pacientes con IC. Método: estudio descriptivo, cuantitativo, desarrollado en hospital terciario, Fortaleza-CE. La población se compone de los pacientes hospitalizados con IC, la muestra de 100 pacientes. Datos fueron recolectados en los registros y entrevista. Aprobado por el Comitê de Ética nº 514/2008. Resultados: prominente mencionar características sociodemográficas como: sexo masculino (63%), edad > 60 años (43%), presencia de factores hereditarios (48%), casadas (67%), jubilados (42%) y los ingresos de la familia

Author(s):  
Edivaldo Cremer ◽  
Almir Conrrado Rodrigues de Lima ◽  
Larissa Laila Cassarotti ◽  
Gabrielle Rodrigues Munhoz ◽  
Romulo Jordão Barbosa Pedrinho ◽  
...  

Objetivou-se descrever as taxas de mortalidade e sobrevida de idosos com insuficiência cardíaca que fizeram uso de digoxina, bem como identificar os fatores de risco associados à mortalidade. Prontuários de pacientes idosos (≥60 anos) atendidos no ambulatório de cardiologia para insuficiência cardíaca e que fizeram uso de digoxina foram triados e selecionados para este estudo retrospectivo. Variáveis sociodemográficas e clínicas foram mensuradas. A sobrevida foi verificada pelas curvas de Kaplan-Meier e teste log-rank. A regressão logística múltipla ajustada foi utilizada para avaliar os potenciais fatores de risco associados à mortalidade. Dos 65 prontuários analisados a sobrevida foi menor nos pacientes que utilizavam a dosagem de 0,125mg (p=0,093). A taxa de mortalidade foi de 35,9% e as chances de óbitos aumentaram nos indivíduos com idade acima de 76 anos (p=0,010; ORaj: 4,021), que possuíam outras doenças cardíacas (p=0,004; ORaj: 5,943) e com maior tempo de uso da digoxina (p=0,047; ORaj: 1,164).Descritores: Digoxina, Mortalidade, Idoso. Mortality of digoxin-treated elderly cardiac subjectsAbstract: This study aimed to describe the mortality and survival rates of elderly with heart failure who used digoxin, as well as to identify the risk factors associated with mortality. Records of elderly patients (≥60 years old) treated at the heart failure outpatient cardiology clinic were screened and selected for this retrospective study. Sociodemographic and clinical variables were measured. Survival was verified by Kaplan-Meier curves and log-rank test. Adjusted multiple logistic regression was used to assess potential risk factors associated with mortality. Of the 65 medical records analyzed, survival was lower in patients using 0.125 mg (p=0.093). The mortality rate was 35.9% and the chances of death increased in individuals over the age of 76 years (p=0.010; ORaj: 4.021), who had other heart disease (p=0.004; ORaj: 5.943) and with longer use of digoxin (p=0.047; ORaj: 1.164).Descriptors: Digoxin, Mortality, Aged. Mortalidad de ancianos cardiacos tratados con digoxinaResumen: El objetivo es describir las tasas de mortalidad y supervivencia de personas mayores con insuficiencia cardíaca que usaban digoxina, así como identificar los factores de riesgo asociados con la mortalidad. Los registros de pacientes ancianos (≥60 años de edad) tratados en la clínica ambulatoria de cardiología con insuficiencia cardíaca se examinaron para este estudio retrospectivo. Se midieron variables sociodemográficas y clínicas. La supervivencia se verificó mediante curvas de Kaplan-Meier y prueba de log-rank. Se utilizó la regresión logística múltiple ajustada para evaluar los posibles factores de riesgo asociados con la mortalidad. De los 65 registros médicos analizados, la supervivencia fue menor en los pacientes que utilizaron 0.125 mg (p=0.093). La tasa de mortalidad fue de 35.9% y las posibilidades de muerte aumentaron en personas mayores de 76 años (p=0.010; ORaj: 4.021), que tenían otras enfermedades cardíacas (p=0.004; ORaj: 5.943) y con uso más prolongado de digoxina (p=0.047; ORaj: 1.164).Descriptores: Digoxina, Mortalidad, Anciano.


Nutrients ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 3994
Author(s):  
Jolanta Malinowska-Borowska ◽  
Aleksandra Kulik ◽  
Marta Buczkowska ◽  
Weronika Ostręga ◽  
Apolonia Stefaniak ◽  
...  

Low spot urinary creatinine concentration (SUCR) is a marker of muscle wasting and clinical outcome. The risk factors for low SUCR in heart failure (HF) remain poorly understood. We explored the risk factors for low SUCR related to poor outcomes. In 721 HF patients (age: 52.3 ± 11 years, female: 14%, NYHA: 2.7 ± 0.7) SUCR and Dexa body composition scans were performed. BMI prior HF-onset, weight loss, and appendicular muscle mass were obtained. Each patient was classified as malnutrition or normal by GLIM criteria and three other biochemical indices (CONUT, PNI, and GRNI). Sarcopenia index (SI) as creatinine to cystatin C ratio was also calculated. Within 1 year, 80 (11.1%) patients died. In ROC curve we identified a SUCR value of 0.628 g/L as optimally discriminating surviving from dead. In low SUCR group more advanced HF, higher weight loss and catabolic components of weight trajectory (CCWT), more frequent under-nutrition by GLIM, and lower SI were observed. In multivariate analysis the independent predictors of low SUCR were SI, CCWT, and GNRI score. In conclusion: the risk of low SUCR was associated with a worse outcome. Low SUCR was associated with greater catabolism and sarcopenia but not with biochemical indices of malnutrition.


2008 ◽  
Vol 65 (12) ◽  
pp. 893-900 ◽  
Author(s):  
Dejan Petrovic ◽  
Biljana Stojimirovic

Background/Aim. Cardiovascular diseases are the leading cause of death in patients treated with hemodialysis (HD). The annual cardiovascular mortality rate in these patients is 9%. Left ventricular (LV) hypertrophy, ischemic heart disease and heart failure are the most prevalent cardiovascular causes of death. The aim of this study was to assess the prevalence of traditional and nontraditional risk factors for cardiovascular complications, to assess the prevalence of cardiovascular complications and overall and cardiovascular mortality rate in patients on HD. Methods. We investigated a total of 115 patients undergoing HD for at least 6 months. First, a cross-sectional study was performed, followed by a two-year follow-up study. Beside standard biochemical parameters, we also determined cardiac troponins and echocardiographic parameters of LV morphology and function (LV mass index, LV fractional shortening, LV ejection fraction). The results were analyzed using the Student's t test and Mann-Whitney U test. Results. The patients with adverse outcome had significantly lower serum albumin (p < 0.01) and higher serum homocystein, troponin I and T, and LV mass index (p < 0.01). Hyperhomocysteinemia, anemia, hypertriglyceridemia and uncontrolled hypertension had the highest prevalence (86.09%, 76.52%, 43.48% and 36.52%, respectively) among all investigated cardiovascular risk factors. Hypertrophy of the LV was presented in 71.31% of the patients and congestive heart failure in 8.70%. Heart valve calcification was found in 48.70% of the patients, pericardial effusion in 25.22% and disrrhythmia in 20.87% of the investigated patients. The average annual overall mortality rate was 13.74%, while average cardiovascular mortality rate was 8.51%. Conclusion. Patients on HD have high risk for cardiovascular morbidity and mortality.


2019 ◽  
Vol 82 (20) ◽  
Author(s):  
Flávia Ribeiro do Carmo ◽  
Harriet Bárbara Maruxo ◽  
Willian Alves dos Santos

Objetiva-se identificar evidências científicas sobre a qualidade de vida em pacientes diagnosticados com insuficiênciacardíaca. Revisão integrativa realizada nas bases de dados Literatura Latino-Americana e do Caribe em Ciências da Saúde(LILACS), Base de Dados de Enfermagem (BDENF) e Sistema Online de Busca e Análise de Literatura Médica (MEDLINE)com a seguinte questão norteadora: Como a insuficiência cardíaca interfere na qualidade de vida dos pacientescardiológicos? Foi utilizada a estratégia PICO com recorte temporal de 2011 a 2016, nos idiomas português, inglês eespanhol. As informações foram tabuladas em programa Microsoft Excel® e processadas a partir de estratégia: médiaaritmética descritiva simples, frequência absoluta e relativa. Encontrou-se 712 artigos na sua totalidade, após aplicaçãodos critérios de inclusão e exclusão foram selecionados 17 artigos científicos avaliados a partir da categoria: os principaisfatores que comprometem a qualidade de vida dos pacientes com insuficiência cardíaca. Conclui-se que os pacientes cominsuficiência cardíaca apresentam intolerância à realização de atividades físicas e têm seu sono prejudicado por conta dadispneia e fadiga, sintomas que contribuem para o declínio da qualidade de vida.Palavras-chave: Insuficiência Cardíaca; Qualidade de Vida; Enfermagem. ABSTRACTThe aim is to identify scientific evidence on the quality of life in patients diagnosed with heart failure. Integrativereview carried out in the Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), Base de Dadosde Enfermagem (BDENF) e Sistema Online de Busca e Análise de Literatura Médica (MEDLINE) databases withthe question: How does heart failure interfere with the quality of life of cardiology patients? The PICO strategywith time cut from 2011 to 2016 was used in Portuguese, English and Spanish. The information was tabulated inMicrosoft Excel® program and processed from strategy: simple descriptive arithmetic mean, absolute and relativefrequency. It found 712 articles in their totality, after applying the inclusion and exclusion criteria, were selected17 scientific articles evaluated from the category: the main factors that compromise the quality of life of patientswith heart failure. It concludes that the patients with heart failure are intolerant to physical activities and sleepimpaired due to dyspnea and fatigue, such symptoms that contribute to the decline of quality of life.Keywords: Heart failure; Quality of life; Nursing.


Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Stephan Rosenkranz ◽  
Marius M Hoeper ◽  
Doerte Huscher ◽  
David Pittrow ◽  
Christian F Opitz

Background: While targeted therapies are available for idiopathic pulmonary arterial hypertension (IPAH), evidence based treatment recommendations for pulmonary hypertension (PH) associated with heart failure and preserved ejection fraction (HFpEF) are lacking. Methods and Results: Out of 5,935 patients in the prospective COMPERA registry, we analyzed patients with “typical” IPAH (n=421, ≤2 of the following risk factors: BMI >30 kg/m2, hypertension, CAD, diabetes and atrial fibrillation at the time of diagnosis), “atypical” IPAH (n=139, >2 risk factors) or PH-HFpEF (n=226) who received targeted PH therapies. Patients with PH-HFpEF, when compared to “typical” and “atypical” IPAH were older (73±8 vs. 62±17 and 71±9 years), had a higher BMI (30 vs. 26 and 32 kg/m2), and more comorbidities (98% vs. 73% and 100%, all p<0.001), respectively. However, mean PAP (46±9 vs. 47±13 and 44±11 mmHg), cardiac index (2.2±0.7 vs. 2,3±0,8 and 2,2±0,8 l/min), and mixed venous oxygen saturation (62±7 vs. 62±10 and 63±9%, all ns) were almost identical. As compared to “typical” and “atypical” IPAH, PH-HFpEF patients had a higher PAWP (20±4 vs. 9±3 and 10±4 mmHg), resulting in a lower calculated PVR (559±270 vs. 861±477 and 784±844 dyn.s.cm-5). Survival at 1, 2 and 3 years post diagnosis was not different between groups. PDE-5 inhibitors were the most common form of initial PH treatment in PH-HFpEF (94%), and combination therapy was less common compared to “typical” or “atypical” IPAH at 1 year (7% vs. 44% and 26%). All 3 groups responded to targeted PH therapies at 12 months, while treatment effects were less pronounced in PH-HFpEF: Compared to baseline, the median increase of the 6MWD at 1 year was 29, 50, and 60 m, respectively. Treatment discontinuations occurred more frequently in patients with PH-HFpEF than in IPAH, either because of side effects or lack of improvement. Conclusions: Despite almost identical alterations of pulmonary artery pressure and cardiac output, patients with PH-HFpEF differed with respect to age, comorbidities and certain hemodynamic features when compared to “typical” or “atypical” IPAH. All groups responded to targeted PH therapy, however tolerability and efficacy of PH drugs were reduced in patients with PH-HFpEF while survival was not different.


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
I.J Lundorff ◽  
M Sengeloev ◽  
S Pedersen ◽  
D Modin ◽  
N.E Bruun ◽  
...  

Abstract Background RV dysfunction is associated with increased mortality and morbidity in patients with heart failure. Due to the complex shape and position of the RV, assessing RV function from echocardiographic images remains a challenge. Purpose We have previously found that global longitudinal strain from 2DSTE is superior to left ventricular ejection fraction (LVEF) in identifying HFrEF patients with high risk of mortality. In this study we wanted to examine RV 2DSTE in patients with HFrEF and compare its prognostic value to conventional RV measures. Methods and results Echocardiographic examinations were retrieved from 701 patients with HFrEF. RV estimates were analysed offline, and end point was all-cause mortality. During follow-up (median 39 months) 118 patients (16.8%) died. RV GLS and RV FWS remained associated with mortality after multivariable adjustment, independent of TAPSE (RV GLS: HR 1.07, 95% CI 1.02–1.13, p=0.010, per 1% decrease) (RV FWS: HR 1.05, 95% CI 1.01–1.09, p=0.010, per 1% decrease). This seemed to be caused by significant associations in men as TAPSE remained as the only independent prognosticator in women. All RV estimates provided prognostic information incremental to established risk factors and significantly increased C-statistics (TAPSE: 0.74 to 0.75; RVFAC: 0.74 to 0.75; RVFWS: 0.74 to 0.77; RVGLS: 0.74 to 0.77). Conclusions RV strain from 2DSTE was associated with mortality in patients with HFrEF, independent of TAPSE and established risk factors. Our results indicate that RV strain is particularly valuable in male patients, whereas in women TAPSE remains a stronger prognosticator. RV GLS and the risk of mortality Funding Acknowledgement Type of funding source: Private company. Main funding source(s): PGJ reports receiving lecture fee from Novo Nordisk.


2008 ◽  
Vol 9 (1) ◽  
pp. 139
Author(s):  
M. Makarewicz-Wujec ◽  
M. Kozłowska-Wojciechowska ◽  
M. Naruszewicz ◽  
A. Mamcarz

2020 ◽  
Vol 73 (2) ◽  
Author(s):  
Ana Paula Dias de Oliveira ◽  
Agueda Maria Ruiz Zimmer Cavalcante ◽  
Camila de Souza Carneiro ◽  
Vinicius Batista Santos ◽  
Sue Moorhead ◽  
...  

ABSTRACT Objectives: To evaluate the effectiveness of NIC interventions “Teaching: Disease Process”, “Health Education” and “Cardiac Care” in the improvement of NOC results in individuals with Heart Failure (HF), and the Nursing Diagnosis (ND) “Ineffective Health Control”. Methods: Retrospective cohort, conducted at a Health Education in Nursing outpatient clinic. Fourteen patients with HF had follow-up for one year in six bimonthly consultations. The effectiveness of interventions was verified through the change of the result scores through the Friedman’s Non-Parametric Test and Analysis of Non-Parametric Variance for repeated measures. The level of significance was 5%. Results: The interventions were implemented in consultations in a variety of activities. There was a significant improvement in the result scores until the fourth visit (p<0.001). Conclusions: The interventions were effective in improving outcomes in patients with HF and Ineffective Health Control.


Sign in / Sign up

Export Citation Format

Share Document